S
SLDB
Solid Bioscience
6.88
+0.26+3.93%Pre Market: 6.95 +0.07 +1.02%06:05 05/27 EDT
OPEN/PREV CLOSE6.76/6.62
TODAY RANGE6.70-6.93
VOL730
MARKET CAP677.33M
52 WEEK RANGE2.830-8.87
AVG VOL (3M)1.31M
% TURNOVER0.80%
TURNOVER--
P/E (TTM)-3.5355
% RANGE3.47%
EPS(TTM)-1.9460
P/E(FORWARD)-3.3725
P/B1.809
BVPS3.802
DIVIDEND--
P/S11.93
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP588.91M
SHARES OUTSTANDING98.45M
NEXT EARNINGS08/10-08/14
FREE FLOAT85.60M
LOT SIZE1
EX-DATE10/28/2022
News
Press Releases
Financial Reports
Profile
Dow Jones·05/18 12:45
Solid Biosciences Price Target Maintained With a $16.00/Share by Wedbush
Benzinga·05/18 12:34
Wedbush Reiterates Outperform on Solid Biosciences, Maintains $16 Price Target
TipRanks·05/15 11:16
H.C. Wainwright Remains a Buy on Solid Biosciences (SLDB)
TipRanks·05/13 20:15
Chardan Capital Sticks to Its Buy Rating for Solid Biosciences (SLDB)
TipRanks·05/13 15:30
Solid Biosciences price target lowered to $16 from $17 at Wedbush
Dow Jones·05/13 14:47
Solid Biosciences Price Target Cut to $16.00/Share From $17.00 by Wedbush
Dow Jones·05/13 14:47
Solid Biosciences Is Maintained at Outperform by Wedbush
Benzinga·05/13 14:37
Wedbush Maintains Outperform on Solid Biosciences, Lowers Price Target to $16
Dow Jones·05/13 13:21
Solid Biosciences Is Maintained at Overweight by Piper Sandler
TipRanks·05/13 12:37
Wedbush Reaffirms Their Buy Rating on Solid Biosciences (SLDB)
TipRanks·05/13 11:12
Solid Biosciences price target raised to $18 from $17 at Piper Sandler
Same Industry
Name/Symbol
Change%
Price